Pharmaceutical Purchase Policy

⪻ On New Articles ⪼

Pharmaceutical Purchase Policy was approved in October 2013 to procure medicines produced by the central PSUs for 5 years and it expired in 2018. The cabinet extended the policy until the closure of Pharma Central Public Sector Undertakings (CPSUs) . It is established to ensure optimum utilization of Central Public Sector Undertakings (CPSUs) with the theme of “availability of medicines at a lower price” .

Pharmaceutical Purchase Policy

Purchase Policy Preview

  • 103 medicines are covered under this policy with quality medicines at nominal prices to the consumers.
  • These medicines will use in government health programs.
  • The Pharmaceutical purchase policy will extend only to Central Public Sector Enterprises and their subsidiaries like Indian Drug and Pharmaceutical Limited (IDPL) , Hindustan Antibiotics Limited (HAL) , Karnataka Antibiotics and Pharmaceutical Limited (KAPL) , etc.
  • The government accounts for or more shares.
  • The National Pharmaceutical Pricing Authority will decide the prices of products and drugs.
  • There would be a discount on all products.
  • As per the Drugs Prices Control Order 2013, the annual revision of prices of these products will consider in the calculation of wholesale price index.
  • The Department of Pharmaceuticals can revive the list of medicines.

Developed by: